肠道菌群与肿瘤的相关研究进展
Research Progress of Intestinal Flora and Tumor
DOI: 10.12677/AMB.2020.94021, PDF,   
作者: 黎雨晴, 杨兴玉, 王未希, 周芳美*：浙江中医药大学医学技术学院，浙江 杭州
关键词: 肠道菌群；肿瘤；发生机制；治疗；Intestinal Flora； Tumor； Pathogenesis； Treatment
摘要: 肠道菌群是人体肠道的微生物，因其数量的庞大有着“人体的第二基因组”之称。这些细菌在人体内相互作用，与人类相互作用，对维持人体健康发挥着重要的作用，而当肠道菌群数量与种类的平衡被打破，机体会出现肠道菌群失调，进而引发肿瘤在内的一系列疾病严重威胁人类健康。研究发现，肠道菌群与恶性肿瘤的发生、发展、治疗效果等密切相关。本文回顾了近年来肠道菌群与肿瘤的相关研究进展，并对未来肠道菌群于肿瘤的发展趋势做出展望，为肿瘤的进一步治疗提供理论依据。
Abstract: Intestinal microflora is the microorganism of human intestinal tract, which is called “the second genome of human body” because of its large number. These bacteria interact in the human body and interact with human beings, which plays an important role in maintaining human health. However, when the balance between the number and species of intestinal flora is broken, the body will have intestinal flora imbalance, which will lead to a series of diseases including cancer, which seriously threaten human health. Studies have found that intestinal flora is closely related to the occurrence, development and therapeutic effect of malignant tumors. In this paper, we reviewed the research progress of intestinal flora and tumor in recent years, and prospected the development trend of intestinal flora in tumor in the future, and provided theoretical basis for further treatment of tumor.
文章引用：黎雨晴, 杨兴玉, 王未希, 周芳美. 肠道菌群与肿瘤的相关研究进展[J]. 微生物前沿, 2020, 9(4): 156-163. https://doi.org/10.12677/AMB.2020.94021

参考文献

[1] Keku Temitope, O., Dulal, S., Deveaux, A., Jovov, B. and Han, X.S. (2015) The Gastrointestinal Microbiota and Colorectal Cancer. American Journal of Physiology: Gastrointestinal and Liver Physiology, 308, G351-G363. [Google Scholar] [CrossRef] [PubMed]
[2] Montalban-Arques, A. and Scharl, M. (2019) Intestinal Microbiota and Colorectal Carcinoma: Implications for Pathogenesis, Diagnosis, and Therapy. EBioMedicine, 48, 648-655. [Google Scholar] [CrossRef] [PubMed]
[3] Konturek, P.C., Haziri, D., Brzozowski, T., et al. (2015) Emerging Role of Fecal Microbiota Therapy in the Treatment of Gastrointestinal and Extra-Gastrointestinal Diseases. Journal of Physiology and Pharmacology, 66, 483-491.
[4] Nayfach, S., Shi, Z.J., Seshadri, R., Pollard, K.S. and Kyrpides, N.C. (2019) New Insights from Uncultivated Genomes of the Global Human Gut Microbiome. Nature, 568, 505-510. [Google Scholar] [CrossRef] [PubMed]
[5] Marchesi, J.R., Adams, D.H., Fava, F., et al. (2015) The Gut Microbiota and Host Health: A New Clinical Frontier. Gut, 65, 330-339. [Google Scholar] [CrossRef] [PubMed]
[6] Nagasaka, M., Sexton, R., Alhasan, R., Rahman, S., Azmi, A.S. and Sukari, A. (2020) Gut Microbiome and Response to Checkpoint Inhibitors in Non-Small Cell Lung Cancer: A Review. Critical Reviews in Oncology/Hematology, 145, Article ID: 102841. [Google Scholar] [CrossRef] [PubMed]
[7] Ganal-Vonarburg, S.C. and Duerr, C.U. (2020) The Interaction of Intestinal Microbiota and Innate Lymphoid Cells in Health and Disease throughout Life. Immunology, 159, 39-51. [Google Scholar] [CrossRef] [PubMed]
[8] 雷中利, 黄燕. 肠道菌群失调在肝癌发生、发展和预防、治疗中的研究进展[J]. 肿瘤药学, 2020, 10(1): 16-20.
[9] Ye, B.X., Stary, C.M., Li, X.J., et al. (2018) Engineering Chimeric Antigen Receptor-T Cells for Cancer Treatment. Molecular Cancer, 17, 32. [Google Scholar] [CrossRef] [PubMed]
[10] Shreiner, A.B., Kao, J.Y. and Young, V.B. (2015) The Gut Microbiome in Health and in Disease. Current Opinion in Gastroenterology, 31, 69-75. [Google Scholar] [CrossRef] 
[11] Khan, M.A.W., Ologun, G., Arora, R., McQuade, J.L. and Wargo, J.A. (2020) Gut Microbiome Modulates Response to Cancer Immunotherapy. Digestive Diseases and Sciences, 65, 885-896. [Google Scholar] [CrossRef] [PubMed]
[12] Belcheva, A., Irrazabal, T., Robertson, S.J., et al. (2014) Gut Microbial Metabolism Drives Transformation of msh2-Deficient Colon Epithelial Cells. Cell, 158, 288-299. [Google Scholar] [CrossRef] [PubMed]
[13] Singh, N., Gurav, A., Sivaprakasam, S., et al. (2014) Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis. Immunity, 40, 128-139. [Google Scholar] [CrossRef] [PubMed]
[14] Dai, Z.W., Coker, O.O., Nakatsu, G., Wu, W.K.K., Zhao, L.Y., Chen, Z.G., Chan, F.K.L., Kristiansen, K., Sung, J.J.Y., Wong, S.H. and Yu, J. (2018) Multi-Cohort Analysis of Colorectal Cancer Metagenome Identified Altered Bacteria across Populations and Universal Bacterial Markers. Microbiome, 6, 70.
[15] Ridlon, J.M., Devendran, S., Alves, J.M., et al. (2019) The “in Vivo Lifestyle” of Bile Acid 7α-Dehydroxylating Bacteria: Comparative Genomics, Metatranscriptomic, and Bile Acid Metabolomics Analysis of a Defined Microbial Community in Gnotobiotic Mice. Gut Microbes, 11, 381-404. [Google Scholar] [CrossRef] [PubMed]
[16] Mizutani, S., Yamada, T. and Yachida, S. (2020) Significance of the Gut Microbiome in Multistep Colorectal Carcinogenesis. Cancer Science, 111, 766-773. [Google Scholar] [CrossRef] [PubMed]
[17] Drewes, J.L., Housseau, F. and Sears, C.L. (2016) Sporadic Colorectal Cancer: Microbial Contributors to Disease Prevention, Development and Therapy. British Journal of Cancer, 115, 273-280. [Google Scholar] [CrossRef] [PubMed]
[18] Komorowski, A.S. and Pezo, R.C. (2020) Untapped “-omics”: The Microbial Metagenome, Estrobolome, and Their Influence on the Development of Breast Cancer and Response to Treatment. Breast Cancer Research and Treatment, 179, 287-300. [Google Scholar] [CrossRef] [PubMed]
[19] 陈菲, 梁婷婷, 吕铮, 李薇, 崔久嵬. 肠道微生态与肿瘤发生和发展关系的研究进展[J]. 肿瘤代谢与营养电子杂志, 2020, 7(1): 7-12.
[20] Wei, M.-Y., Shi, S., Liang, C., Meng, Q.-C., Hua, J., Zhang, Y.-Y., Liu, J., Zhang, B., Xu, J. and Yu, X.-J. (2019) The Microbiota and Microbiome in Pancreatic Cancer: More Influential than Expected. Molecular Cancer, 18, Article No. 97. [Google Scholar] [CrossRef] [PubMed]
[21] Brennan, C.A. and Garrett, W.S. (2016) Gut Microbiota, Inflammation, and Colorectal Cancer. Annual Review of Microbiology, 70, 395-411. [Google Scholar] [CrossRef] [PubMed]
[22] Zmora, N., Levy, M., Pevsner-Fishcer, M. and Elinav, E. (2017) Inflammasomes and Intestinal Inflammation. Mucosal Immunology, 10, 865-883. [Google Scholar] [CrossRef] [PubMed]
[23] Wei, M.Y., Shi, S., Liang, C., Meng, Q.C., Hua, J., Zhang, Y.Y., Liu, J., Zhang, B., Xu, J. and Yu, X.J. (2019) The Microbiota and Microbiome in Pancreatic Cancer: More Influential than Expected. Molecular Cancer, 18, 97. [Google Scholar] [CrossRef] [PubMed]
[24] Serra, N., Di Carlo, P., Gulotta, G., d’Arpa, F., Giammanco, A., Colomba, C., Melfa, G., Fasciana, T. and Sergi, C. (2018) Bactibilia in Women Affected with Diseases of the Biliary Tract and Pancreas. A STROBE Guidelines-Adherent Cross-Sectional Study in Southern Italy. Journal of Medical Microbiology, 67, 1090-1095. [Google Scholar] [CrossRef] [PubMed]
[25] Brennan, C.A. and Garrett, W.S. (2016) Gut Microbiota, Inflammation, and Colorectal Cancer. Annual Review of Microbiology, 70, 395-411. [Google Scholar] [CrossRef] [PubMed]
[26] Parkin, D.M. (2006) The Global Health Burden of Infection-Associated Cancers in the Year 2002. International Journal of Cancer, 118, 3030-3044. [Google Scholar] [CrossRef] [PubMed]
[27] Kostic, A.D., Chun, E., Robertson, L., Glickman, J.N., Gallini, C.A., Michaud, M., Clancy, T.E., Chung, D.C., Lochhead, P., Hold, G.L., El-Omar, E.M., Brenner, D., Fuchs, C.S., Meyerson, M. and Garrett, W.S. (2013) Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment. Cell Host Microbe, 14, 207-215. [Google Scholar] [CrossRef] [PubMed]
[28] Gagnière, J., Raisch, J., Veziant, J., et al. (2016) Gut Microbiota Imbalance and Colorectal Cancer. World Journal of Gastroenterology, 22, 501-518. [Google Scholar] [CrossRef] [PubMed]
[29] Uribe-Herranz, M., Rafail, S., Beghi, S., Gil-de-Gómez, L., Verginadis, I., Bittinger, K., Pustylnikov, S., Pierini, S., Perales-Linares, R., Blair, I.A., Mesaros, C.A., Snyder, N.W., Bushman, F., Koumenis, C. and Facciabene, A. (2020) Gut Microbiota Modulate Dendritic Cell Antigen Presentation and Radiotherapy-Induced Antitumor Immune Response. Journal of Clinical Investigation, 130, 466-479. [Google Scholar] [CrossRef] 
[30] Zhou, J. and Boutros, M. (2020) JNK-Dependent Intestinal Barrier Failure Disrupts Host-Microbe Homeostasis during Tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America, 117, 9401-9412. [Google Scholar] [CrossRef] [PubMed]
[31] Wu, S., Rhee, K.J., Zhang, M., Franco, A. and Sears, C.L. (2007) Bacteroides fragilis Toxin Stimulates Intestinal Epithelial Cell Shedding and Gamma-Secretase-Dependent E-Cadherin Cleavage. Journal of Cell Science, 120, 1944-1952. [Google Scholar] [CrossRef] [PubMed]
[32] Baffy, G. (2020) Gut Microbiota and Cancer of the Host: Colliding Interests. Advances in Experimental Medicine and Biology, 1219, 93-107. [Google Scholar] [CrossRef] [PubMed]
[33] 刘光峨, 马虎. 非小细胞肺癌免疫治疗相关生物标记物的研究进展[J]. 山东医药, 2020, 60(13): 100-103.
[34] Gopalakrishnan, V., Helmink, B.A., Spencer, C.N., Reuben, A. and Wargo, J.A. (2018) The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy. Cancer Cell, 33, 570-580. [Google Scholar] [CrossRef] [PubMed]
[35] Iida, N., Dzutsev, A., Stewart, C.A., Smith, L., Bouladoux, N., Weingarten, R., Molina, D.A., Salcedo, R., Back, T., Cramer, S., Dai, R.M., Kiu, H., Cardone, M., Naik, S., Patri, A.K., Wang, E., Marincola, F.M., Frank, K.M., Belkaid, Y., Trinchieri, G. and Goldszmid, R.S. (2013) Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment. Science, 342, 967-970. [Google Scholar] [CrossRef] [PubMed]
[36] Gopalakrishnan, V., Spencer, C.N., Nezi, L., et al. (2018) Gut Microbiome Modulates Response to Anti-PD-1 Immunotherapy in Melanoma Patients. Science, 359, 97-103.
[37] Vétizou, M., Pitt, J.M., Daillère, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M.P., Duong, C.P., Poirier-Colame, V., Roux, A., Becharef, S., Formenti, S., Golden, E., Cording, S., Eberl, G., Schlitzer, A., Ginhoux, F., Mani, S., Yamazaki, T., Jacquelot, N., Enot, D.P., Bérard, M., Nigou, J., Opolon, P., Eggermont, A., Woerther, P.L., Chachaty, E., Chaput, N., Robert, C., Mateus, C., Kroemer, G., Raoult, D., Boneca, I.G., Carbonnel, F., Chamaillard, M. and Zitvogel, L. (2015) Anticancer Immunotherapy by CTLA-4 Blockade Relies on the Gut Microbiota. Science, 350, 1079-1084. [Google Scholar] [CrossRef] [PubMed]
[38] Ma, W., Mao, Q., Xia, W., Dong, G., Yu, C. and Jiang, F. (2019) Gut Microbiota Shapes the Efficiency of Cancer Therapy. Frontiers in Microbiology, 10, 1050. [Google Scholar] [CrossRef] [PubMed]
[39] Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillère, R., Hannani, D., et al. (2013) The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide. Science, 342, 971-976. [Google Scholar] [CrossRef] [PubMed]
[40] Daillère, R., Vétizou, M., Waldschmitt, N., Yamazaki, T., Isnard, C., Poirier-Colame, V., et al. (2016) Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects. Immunity, 45, 931-943. [Google Scholar] [CrossRef] [PubMed]
[41] Yu, T., Guo, F., Yu, Y., Sun, T., Ma, D., Han, J., Qian, Y., Kryczek, I., Sun, D., Nagarsheth, N., Chen, Y., Chen, H., Hong, J., Zou, W. and Fang, J.Y. (2017) Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy. Cell, 170, 548-563. [Google Scholar] [CrossRef] [PubMed]
[42] Villéger, R., Lopès, A., Carrier, G., et al. (2019) Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment? International Journal of Molecular Sciences, 20, 4584.
[43] Cui, M., Xiao, H., Luo, D., Zhang, X., Zhao, S., Zheng, Q., Li, Y., Zhao, Y., Dong, J., Li, H., et al. (2016) Circadian Rhythm Shapes the Gut Microbiota Affecting Host Radiosensitivity. International Journal of Molecular Sciences, 17, 1786. [Google Scholar] [CrossRef] [PubMed]
[44] Blair, I.A., Mesaros, C.A., Snyder, N.W., Bushman, F., Koumenis, C. and Facciabene, A. (2020) Gut Microbiota Modulate Dendritic Cell Antigen Presentation and Radiotherapy-Induced Antitumor Immune Response. Journal of Clinical Investigation, 130, 466-479. [Google Scholar] [CrossRef] 
[45] Hekmatshoar, Y., Saadat, Y.R., Khatibi, S.M.H., Ozkan, T., Vahed, F.Z., Nariman-Saleh-Fam, Z., Gargari, B.P., Sunguroglu, A. and Vahed, S.Z. (2019) The Impact of Tumor and Gut Microbiotas on Cancer Therapy: Beneficial or Detrimental? Life Sciences, 233, Article ID: 116680. [Google Scholar] [CrossRef] [PubMed]
[46] 薛越, 王青青. 肠道菌群与恶性肿瘤的研究进展[J]. 实用肿瘤杂志, 2016, 31(1): 9-13.
[47] Gensollen, T., Iyer, S.S., Kasper, D.L. and Blumberg, R.S. (2016) How Colonization by Microbiota in Early Life Shapes the Immune System. Science, 352, 539-544. [Google Scholar] [CrossRef] [PubMed]

为你推荐